Trial Profile
A Phase II Study of Carfilzomib in Relapsed Waldenstrom's Macroglobulinemia (WM) IST-CAR-531
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Apr 2022
Price :
$35
*
At a glance
- Drugs Carfilzomib (Primary) ; Dexamethasone; Rituximab
- Indications Waldenstrom's macroglobulinaemia
- Focus Therapeutic Use
- 18 Mar 2022 Status changed from active, no longer recruiting to completed.
- 21 Aug 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov.
- 21 Aug 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.